BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1687300)

  • 1. [Prognostic indices for the course of HIV infection].
    Hess G
    Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The George M. Kober lecture. Basic immunology: the path to the delineation of the immunopathogenic mechanisms of HIV infection.
    Fauci AS
    Trans Assoc Am Physicians; 1988; 101():clx-clxxiii. PubMed ID: 2908369
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of CD28 costimulation on HIV production by CD4+ cells.
    Barker E; Bossart KN; Levy JA
    J Immunol; 1998 Dec; 161(11):6223-7. PubMed ID: 9834109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and HIV infection.
    Sadat-Sowti B; Debre P
    Eur Cytokine Netw; 1992; 3(6):515-21. PubMed ID: 1363594
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
    J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
    Peretz Y; Ndongala ML; Boulet S; Boulassel MR; Rouleau D; Côté P; Longpré D; Routy JP; Falutz J; Tremblay C; Tsoukas CM; Sékaly RP; Bernard NF
    Clin Immunol; 2007 Jul; 124(1):57-68. PubMed ID: 17521962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HIV drugs work rapidly or not at all. Virus dynamics--therapeutic consequences].
    Aulehla S
    Fortschr Med; 1995 Apr; 113(12):14-6. PubMed ID: 7789929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Classification of HIV-associated acquired immunologic deficiency syndrome].
    Bauer R; Schmitt A; Niedecken HW; Kreysel HW
    Z Hautkr; 1989 Sep; 64(9):788, 791-4, 797. PubMed ID: 2573210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How resting T cells deMURR HIV infection.
    Greene WC
    Nat Immunol; 2004 Jan; 5(1):18-9. PubMed ID: 14699403
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA; van Baarle D; Miedema F
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
    Grossman Z; Meier-Schellersheim M; Sousa AE; Victorino RM; Paul WE
    Nat Med; 2002 Apr; 8(4):319-23. PubMed ID: 11927927
    [No Abstract]   [Full Text] [Related]  

  • 17. Profile of T cell immune responses in HIV-infected children from Uganda.
    Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
    J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness.
    Feller L; Khammissa RA; Wood NH; Meyerov R; Lemmer J
    SADJ; 2008 Nov; 63(10):552, 554, 556-7. PubMed ID: 19322966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Different sensitivity of productively HIV-I infected and non-infected cells to apoptosis].
    Boĭchuk SV; Ivanov AV; Mustafin Ig; Makarova MV; Dunaev PD; Aleksander L
    Patol Fiziol Eksp Ter; 2008; (4):7-9. PubMed ID: 19198264
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
    Hofmann B; Wang YX; Cumberland WG; Detels R; Bozorgmehri M; Fahey JL
    AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.